Barbara Gayle Duncan Atea Pharmaceuticals, Inc. (AVIR) insider trading activity
Barbara Gayle Duncan is of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 62,750 shares of AVIR, which is worth approximately $228,410. The most recent transaction as insider was on Jun 20, 2025, when has been sold 29,600 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
62.8K
89.29%
3M change
89.29%
12M change
Total Value Held
$228,410
Barbara Gayle Duncan Transaction History
Also insider at
BGD
Barbara Gayle Duncan
Boston, MA